APA

Wang B., Li F., Cheng L., Zhan Y., Wu B., Chen P., Shen J., Wu W., Ma X., Zhu J., Pan B., Guo W. & Cheng Y. (20190624). The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma. : Future oncology (London, England).

Chicago

Wang Beili, Li Feng, Cheng Luya, Zhan Yanxia, Wu Boting, Chen Pu, Shen Junfei, Wu Wenhao, Ma Xiaolu, Zhu Jie, Pan Baishen, Guo Wei and Cheng Yunfeng. 20190624. The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma. : Future oncology (London, England).

Harvard

Wang B., Li F., Cheng L., Zhan Y., Wu B., Chen P., Shen J., Wu W., Ma X., Zhu J., Pan B., Guo W. and Cheng Y. (20190624). The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma. : Future oncology (London, England).

MLA

Wang Beili, Li Feng, Cheng Luya, Zhan Yanxia, Wu Boting, Chen Pu, Shen Junfei, Wu Wenhao, Ma Xiaolu, Zhu Jie, Pan Baishen, Guo Wei and Cheng Yunfeng. The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma. : Future oncology (London, England). 20190624.